Colorectal cancer

You can now review and comment on this draft guideline.

The consultation closes on 5pm on 13^th September 2019

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline– just the recommendations
• Evidence reviews:

Evidence review A1 - Prevention of CRC in people with Lynch syndromes

Evidence review B1 - Molecular biomarkers

Evidence review C1 - Early rectal cancer

Evidence review C2 - Preoperative therapy for rectal cancer

Evidence review C3 - Surgical technique for rectal cancer

Evidence review C4 - Deferral of surgery for rectal cancer

Evidence review C5 - Pelvic exenteration

Evidence review C6 - Endoscopic resection along for early colon cancer

Evidence review C7 - Preoperative chemotherapy for colon cancer

Evidence review C8 - Duration of adjuvant chemotherapy

Evidence review C9 - Colonic stenting

Evidence review D1 - Asymptomatic primary tumour

Evidence review D2a - Metastatic CRC in the liver amenable to treatment with curative intent

Evidence review D2b - Metastatic CRC in the liver not amenable to treatment with curative intent

Evidence review D3 - Metastic CRC in the lung

Evidence review D4 - Metastatic CRC in the periotoneum

Evidence review E1 - Follow-up

Evidence review E2 - Management of LARS

Evidence review E3 - Information needs

Evidence review F1 - Surgical volumes

• Supporting documentation:

Supporting documentation 1 - Methods

Supporting documentation 2 - Health economics

Supporting documentation 3 - Glossary

Supporting documentation 4 - NGA team list

• Economic models

If you want to review the economic models, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment
• Committee membership list and DOI register
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: ColorectalCancer@nice.org.uk

Deadline: 5pm on 13^th September 2019

5. Economic model

The developer has produced an economic model to support the guideline on Colorectal cancer: diagnosis and management (update). To receive an executable version of this model, please submit a request to ColorectalCancer@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation:5pm on 13^th September 2019.